Macrolides: a promising pharmacologic therapy for chronic obstructive pulmonary disease
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Macrolides: a promising pharmacologic therapy for chronic obstructive pulmonary disease
Authors
Keywords
-
Journal
Therapeutic Advances in Respiratory Disease
Volume 11, Issue 3, Pages 147-155
Publisher
SAGE Publications
Online
2017-03-06
DOI
10.1177/1753465816682677
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Combination of erythromycin and dexamethasone improves corticosteroid sensitivity induced by CSE through inhibiting PI3K-δ/Akt pathway and increasing GR expression
- (2015) Xue-Jiao Sun et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Anti-inflammatory effects of a novel non-antibiotic macrolide, EM900, on mucus secretion of airway epithelium
- (2015) Ichiro Tojima et al. AURIS NASUS LARYNX
- Non-antibiotic 12-membered macrolides: design, synthesis and biological evaluation in a cigarette-smoking model
- (2015) Akihiro Sugawara et al. JOURNAL OF ANTIBIOTICS
- The role of viral infections in exacerbations of chronic obstructive pulmonary disease and asthma
- (2015) Richard Hewitt et al. Therapeutic Advances in Respiratory Disease
- Predictors of Chronic Obstructive Pulmonary Disease Exacerbation Reduction in Response to Daily Azithromycin Therapy
- (2014) MeiLan K. Han et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Azithromycin analogue CSY0073 attenuates lung inflammation induced by LPS challenge
- (2014) V Balloy et al. BRITISH JOURNAL OF PHARMACOLOGY
- Association of Azithromycin With Mortality and Cardiovascular Events Among Older Patients Hospitalized With Pneumonia
- (2014) Eric M. Mortensen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The Effect of Azithromycin in Adults with Stable Neutrophilic COPD: A Double Blind Randomised, Placebo Controlled Trial
- (2014) Jodie L. Simpson et al. PLoS One
- Azithromycin maintenance treatment in patients with frequent exacerbations of chronic obstructive pulmonary disease (COLUMBUS): a randomised, double-blind, placebo-controlled trial
- (2014) Sevim Uzun et al. Lancet Respiratory Medicine
- Prognostic Value of Bronchiectasis in Patients with Moderate-to-Severe Chronic Obstructive Pulmonary Disease
- (2013) Miguel-Angel Martínez-García et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- A novel macrolide/fluoroketolide, solithromycin (CEM-101), reverses corticosteroid insensitivity via phosphoinositide 3-kinase pathway inhibition
- (2013) Y Kobayashi et al. BRITISH JOURNAL OF PHARMACOLOGY
- Persistence of Th17/Tc17 Cell Expression upon Smoking Cessation in Mice with Cigarette Smoke-Induced Emphysema
- (2013) Min-Chao Duan et al. Clinical & Developmental Immunology
- Effect of Long-term, Low-Dose Erythromycin on Pulmonary Exacerbations Among Patients With Non–Cystic Fibrosis Bronchiectasis
- (2013) David J. Serisier et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of Azithromycin Maintenance Treatment on Infectious Exacerbations Among Patients With Non–Cystic Fibrosis Bronchiectasis
- (2013) Josje Altenburg et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Corticosteroid resistance in patients with asthma and chronic obstructive pulmonary disease
- (2013) Peter J. Barnes JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Use of Azithromycin and Death from Cardiovascular Causes
- (2013) Henrik Svanström et al. NEW ENGLAND JOURNAL OF MEDICINE
- EM, EM703 inhibit NF-kB activation induced by oxidative stress from diesel exhaust particle in human bronchial epithelial cells: Importance in IL-8 transcription
- (2013) Ying-Ji Li et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Macrolide Therapy Decreases Chronic Obstructive Pulmonary Disease Exacerbation: A Meta-Analysis
- (2013) Guo-Yan Yao et al. RESPIRATION
- Risks of population antimicrobial resistance associated with chronic macrolide use for inflammatory airway diseases
- (2013) David J Serisier Lancet Respiratory Medicine
- Long-term macrolide treatment for chronic respiratory disease
- (2012) Paolo Spagnolo et al. EUROPEAN RESPIRATORY JOURNAL
- Effect of erythromycin on cigarette-induced histone deacetylase protein expression and nuclear factor-κB activity in human macrophages in vitro
- (2012) Meihua Li et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Increased expression of CD4+IL-17+ cells in the lung tissue of patients with stable chronic obstructive pulmonary disease (COPD) and smokers
- (2012) Jianquan Zhang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial
- (2012) Conroy Wong et al. LANCET
- Erythromycin EnhancesCD4+Foxp3+Regulatory T-Cell Responses in a Rat Model of Smoke-Induced Lung Inflammation
- (2012) Jing Bai et al. MEDIATORS OF INFLAMMATION
- Azithromycin and the Risk of Cardiovascular Death
- (2012) Wayne A. Ray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Development of non-antibiotic macrolide that corrects inflammation-driven immune dysfunction in models of inflammatory bowel diseases and arthritis
- (2011) Andrea Mencarelli et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- The expression of Foxp3 and ROR gamma t in lung tissues from normal smokers and chronic obstructive pulmonary disease patients
- (2011) Shuyuan Chu et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Azithromycin for Prevention of Exacerbations of COPD
- (2011) Richard K. Albert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Erythromycin prevents the pulmonary inflammation induced by exposure to cigarette smoke
- (2011) Shinichiro Mikura et al. Translational Research
- Erythromycin ameliorates cigarette-smoke–induced emphysema and inflammation in rats
- (2011) Yan Zhou et al. Translational Research
- Long-term azithromycin therapy in patients with severe COPD and repeated exacerbations
- (2011) Xavier Pomares Amigó et al. International Journal of Chronic Obstructive Pulmonary Disease
- Chronic Obstructive Pulmonary Disease Phenotypes
- (2010) MeiLan K. Han et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Mechanisms of Action and Clinical Application of Macrolides as Immunomodulatory Medications
- (2010) S. Kanoh et al. CLINICAL MICROBIOLOGY REVIEWS
- Effect of 6 Months of Erythromycin Treatment on Inflammatory Cells in Induced Sputum and Exacerbations in Chronic Obstructive Pulmonary Disease
- (2010) Zhi-Yi He et al. RESPIRATION
- Long-term macrolide therapy in chronic inflammatory airway diseases
- (2009) P. A. J. Crosbie et al. EUROPEAN RESPIRATORY JOURNAL
- Annual macrolide prescription rates and the emergence of macrolide resistance among Streptococcus pneumoniae in Canada from 1995 to 2005
- (2009) James A. Karlowsky et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Immunologic Aspects of Chronic Obstructive Pulmonary Disease
- (2009) Manuel G. Cosio et al. NEW ENGLAND JOURNAL OF MEDICINE
- Long-term Erythromycin Therapy Is Associated with Decreased Chronic Obstructive Pulmonary Disease Exacerbations
- (2008) Terence A. R. Seemungal et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Molecular Mechanisms of Corticosteroid Resistance
- (2008) Ian M. Adcock et al. CHEST
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now